Registration number of additive | Name and registration number of person responsible for putting additive into circulation |
Additive
(trade name)
Composition, chemical formula, description | Species or category of animal | Maximum age | Minimum content | Maximum content | Other provisions | End of period of authorisation | Provisional maximum residue limits (MRLs) in the relevant foodstuffs of animal origin
mg of active substance/kg of complete feedingstuff
Coccidiostats and other medicinal substances
‘E 757 | Eli Lilly and Company Limited | Monensin sodium (Elancoban G100, Elancoban 100, Elancogran 100, Elancoban G200, Elancoban 200) |
Active substanc:
C36H61O11Na
sodium salt of polyether monocarboxylic acid produced by Streptomyces cinnamonensis, ATCC 15413 in granular form.
Factor composition:
Monensin A: not less than 90 %
Monensin: A + B: not less than 95 %
Additive composition:
Granular monensin (dried fermentation product) equivalent to Monensin activity 10 % w/w
Mineral oil 1-3 % w/w
Limestone granular 13-23 % w/w
Rice hulls or limestone granular qs 100 % w/w
Granular monensin (dried fermentation product) equivalent to Monensin activity 20 % w/w
Mineral oil 1-3 % w/w
Rice hulls or limestone granular qs 100 % w/w
Chickens for fattening | — | 100 | 125 |
Use prohibited at least three days before slaughter. Indicate in the instructions for use:
“Dangerous for equines. This feedingstuff contains an ionophore: avoid simultaneous administration with tiamulin and monitor for possible adverse reactions when used concurrently with other medicinal substances”
30.7.2014 |
25 μg monensin sodium/kg of wet skin + fat.
8 μg monensin sodium/kg of wet liver, kidney and muscle’.
Chickens reared for laying | 16 weeks | 100 | 120
Turkeys | 16 weeks | 60 | 100